Human Health Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents

Reuters

2025/09/25

<a href="https://laohu8.com/S/01419">Human Health</a> Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents

Human Health Holdings Ltd. reported revenue of HK$644.4 million for the year ended 30 June 2025, compared to HK$590.8 million in the previous year. Basic earnings per share for FY2025 were approximately HK6.9 cents, up from HK6.4 cents in FY2024. The company's Board proposed a final dividend of HK3.0 cents per share for FY2025, compared to HK2.8 cents in the prior year. The Group noted a slight decline in revenue excluding acquisitions and stated that it has adopted a forward-looking strategy to strengthen its presence and long-term prospects in the market. No further details on outlook or guidance were provided in the announcement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Human Health Holdings Ltd. published the original content used to generate this news brief on September 25, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2570373013"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570373013\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570373013?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570373013","market":"fut","top_or_hot":-1,"title":"Human Health Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/01419\">Human Health</a> Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Human Health Holdings Ltd. reported revenue of HK$644.4 million for the year ended 30 June 2025, compared to HK$590.8 million in the previous year. Basic earnings per share for FY2025 were approximately HK6.9 cents, up from HK6.4 cents in FY2024. The company's Board proposed a final dividend of HK3.0 cents per share for FY2025, compared to HK2.8 cents in the prior year. The Group noted a slight decline in revenue excluding acquisitions and stated that it has adopted a forward-looking strategy to strengthen its presence and long-term prospects in the market. No further details on outlook or guidance were provided in the announcement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Human Health Holdings Ltd. published the original content used to generate this news brief on September 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Human Health Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHuman Health Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-09-25 21:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/01419\">Human Health</a> Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Human Health Holdings Ltd. reported revenue of HK$644.4 million for the year ended 30 June 2025, compared to HK$590.8 million in the previous year. Basic earnings per share for FY2025 were approximately HK6.9 cents, up from HK6.4 cents in FY2024. The company's Board proposed a final dividend of HK3.0 cents per share for FY2025, compared to HK2.8 cents in the prior year. The Group noted a slight decline in revenue excluding acquisitions and stated that it has adopted a forward-looking strategy to strengthen its presence and long-term prospects in the market. No further details on outlook or guidance were provided in the announcement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Human Health Holdings Ltd. published the original content used to generate this news brief on September 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01419","symbol_name":"盈健醫療","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250925:nNDL7CBPb:1","article_id":"2570373013","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570373013","pubTimestamp":1758807246,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Human Health Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents. Human Health Holdings Ltd. reported revenue of HK$644.4 million for the year ended 30 June 2025, compared to HK$590.8 million in the previous year. Basic earnings per share for FY2025 were approximately HK6.9 cents, up from HK6.4 cents in FY2024. The company's Board proposed a final dividend of HK3.0 cents per share for FY2025, compared to HK2.8 cents in the prior year. The Group noted a slight decline in revenue excluding acquisitions and stated that it has adopted a forward-looking strategy to strengthen its presence and long-term prospects in the market. No further details on outlook or guidance were provided in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only an","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01419":"盈健医疗","BK1219":"保健护理服务"},"translate_title":"Human Health Holdings 2025财年收入增长9.1%至6.444亿港元；净利润增长8.9%至26.3百万港元；每股收益6.9港仙","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01419":0.9},"content_text":"Human Health Holdings FY2025 Revenue Rises 9.1% to HK$644.4 Million; Net Profit Up 8.9% to HK$26.3 Million; EPS at HK6.9 Cents\n    \n\n        Human Health Holdings Ltd. reported revenue of HK$644.4 million for the year ended 30 June 2025, compared to HK$590.8 million in the previous year. Basic earnings per share for FY2025 were approximately HK6.9 cents, up from HK6.4 cents in FY2024. The company's Board proposed a final dividend of HK3.0 cents per share for FY2025, compared to HK2.8 cents in the prior year. The Group noted a slight decline in revenue excluding acquisitions and stated that it has adopted a forward-looking strategy to strengthen its presence and long-term prospects in the market. No further details on outlook or guidance were provided in the announcement.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Human Health Holdings Ltd. published the original content used to generate this news brief on September 25, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive,dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}